Evidence map›Paper›PMID 33661159›Full record

ReviewCurrent opinion in neurology2021

Central nervous system tuberculosis.

Sofiati Dian, Ahmad Rizal Ganiem, Arjan van Laarhoven

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. An overview on central nervous system tuberculosis (CNS-TB) focusing on cognitive impairments.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Brain abscess caused byThe Journal of international medical research · 2024
    Review
  18. Article
  19. ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Sofiati DianDepartment of Neurology, Faculty of Medicine, Universitas Padjadjaran/Dr Hasan Sadikin General Hospital.
Ahmad Rizal GaniemDepartment of Neurology, Faculty of Medicine, Universitas Padjadjaran/Dr Hasan Sadikin General Hospital.
Arjan van LaarhovenDepartment of Internal Medicine Radboud University Medical Center, Nijmegen, the Netherlands.
Dr. Hasan Sadikin General Hospital · IDPadjadjaran University · IDRadboud University Nijmegen · NL

Funding

ULTIMATER01AI145781 · NIAID · STICHTING RADBOUD UNIVERSITEIT · PI THWAITES, GUY, VAN CREVEL, REINOUT · 2019 to 2023
$4.4M
Medical Research Council MR/S004963/1NIAID NIH HHS R01 AI145781
6 · The paper itself

Abstract

purpose of reviewCentral nervous system (CNS) tuberculosis is the most devastating form of tuberculosis (TB), with mortality and or neurological sequelae in over half of individuals. We reviewed original research and systematic reviews published since 1 January 2019 for new developments in CNS TB pathophysiology, diagnosis, management and prognosis. RECENT

findingsInsight in the pathophysiology is increasing steadily since the landmark studies in 1933, focussing on granuloma type classification, the relevance of the M. tuberculosis bacterial burden and the wide range of immunological responses. Although Xpert/RIF has been recommended by the WHO for extrapulmonary TB diagnosis, culture is still needed to increase the sensitivity of TB meningitis diagnosis. Sequential MRIs can improve understanding of neurological deficits at baseline and during treatment. Pharmacokinetic/pharmacodynamic modelling suggests that higher doses of rifampicin and isoniazid in TB meningitis could improve survival. SUMMARY: Recent studies in the field of CNS-TB have largely focussed on TB meningitis. The outcome may improve by optimizing treatment dosing. This needs to be confirmed in clinical trials. Due to the important role of inflammation, these trials should be used as the platform to study the inflammatory and metabolomic responses. This could improve understanding of the biology of this disease and improve patient outlook by enabling individualised host-directed therapy.

Indexed as

Mycobacterium tuberculosisTuberculosis, Central Nervous SystemAntibiotics, AntitubercularDrug Resistance, BacterialHumansMicrobial Sensitivity TestsSensitivity and SpecificityTuberculosis, PulmonaryAntibiotics, Antitubercular

Identifiers

PMID33661159
PMCPMC8283909
OpenAlexW3146474096

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.